These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 12505685)

  • 21. 1-Benzyl-1,2,3,4-tetrahydroisoquinoline passes through the blood-brain barrier of rat brain: an in vivo microdialysis study.
    Song Y; Feng Y; Leblanc MH; Castagloni N; Liu YM
    Neurosci Lett; 2006 Feb; 395(1):63-6. PubMed ID: 16289318
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regional distribution of parkinsonism-preventing endogenous tetrahydroisoquinoline derivatives and an endogenous parkinsonism-preventing substance-synthesizing enzyme in monkey brain.
    Yamakawa T; Kotake Y; Fujitani M; Shintani H; Makino Y; Ohta S
    Neurosci Lett; 1999 Nov; 276(1):68-70. PubMed ID: 10586977
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [123I]FP-CIT binds to the dopamine transporter as assessed by biodistribution studies in rats and SPECT studies in MPTP-lesioned monkeys.
    Booij J; Andringa G; Rijks LJ; Vermeulen RJ; De Bruin K; Boer GJ; Janssen AG; Van Royen EA
    Synapse; 1997 Nov; 27(3):183-90. PubMed ID: 9329154
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 1-Methyl-1,2,3,4-tetrahydroisoquinoline, decreasing in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mouse, prevents parkinsonism-like behavior abnormalities.
    Tasaki Y; Makino Y; Ohta S; Hirobe M
    J Neurochem; 1991 Dec; 57(6):1940-3. PubMed ID: 1940911
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and neurotoxicity of tetrahydroisoquinoline derivatives for studying Parkinson's disease.
    Abe K; Saitoh T; Horiguchi Y; Utsunomiya I; Taguchi K
    Biol Pharm Bull; 2005 Aug; 28(8):1355-62. PubMed ID: 16079473
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selective inhibition of complex I by N-methylisoquinolinium ion and N-methyl-1,2,3,4-tetrahydroisoquinoline in isolated mitochondria prepared from mouse brain.
    Suzuki K; Mizuno Y; Yamauchi Y; Nagatsu T; Mitsuo Y
    J Neurol Sci; 1992 Jun; 109(2):219-23. PubMed ID: 1353109
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of the haloperidol tetrahydropyridine metabolite 4-(4-chlorophenyl)-1-[4-(4-fluorophenyl)-4-oxobutyl]-1,2,3,6- tetrahydropyridine on dopamine receptor and transporter binding. A nonhuman primate 123I-iodobenzamide and 2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane single photon emission computed tomographic study.
    Oliver DW; Dormehl IC; Van der Schyf CJ; Neumeyer JL; Hugo N; Keeve R; Rossouw NT; Müller-Gärtner HW; Castagnoli N
    Arzneimittelforschung; 1997 Jun; 47(6):692-9. PubMed ID: 9239444
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of a tropane radioligand, [(3)H]2beta-propanoyl-3beta-(4-tolyl) tropane ([(3)H]PTT), for dopamine transport sites in rat brain.
    Letchworth SR; Smith HR; Porrino LJ; Bennett BA; Davies HM; Sexton T; Childers SR
    J Pharmacol Exp Ther; 2000 May; 293(2):686-96. PubMed ID: 10773045
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduction of rat brain levels of the endogenous dopaminergic proneurotoxins 1,2,3,4-tetrahydroisoquinoline and 1,2,3,4-tetrahydro-beta-carboline by cigarette smoke.
    Soto-Otero R; Méndez-Alvarez E; Sánchez-Sellero I; Cruz-Landeira A; López-Rivadulla Lamas M
    Neurosci Lett; 2001 Feb; 298(3):187-90. PubMed ID: 11165438
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the Effects of Acute and Chronic Administration of Tetrahydroisoquinoline Amines on the In Vivo Dopamine Release: A Microdialysis Study in the Rat Striatum.
    Wąsik A; Romańska I; Antkiewicz-Michaluk L
    Neurotox Res; 2016 Nov; 30(4):648-657. PubMed ID: 27568335
    [TBL] [Abstract][Full Text] [Related]  

  • 31. N-substituted analogs of 2 beta-carbomethoxy-3 beta- (4'-iodophenyl)tropane (beta-CIT) with selective affinity to dopamine or serotonin transporters in rat forebrain.
    Neumeyer JL; Tamagnan G; Wang S; Gao Y; Milius RA; Kula NS; Baldessarini RJ
    J Med Chem; 1996 Jan; 39(2):543-8. PubMed ID: 8558525
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of dopaminergic drugs on the in vivo binding of [3H]WIN 35,428 to central dopamine transporters.
    Scheffel U; Steinert C; Kim SE; Ehlers MD; Boja JW; Kuhar MJ
    Synapse; 1996 Jun; 23(2):61-9. PubMed ID: 8723710
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mapping genes that regulate density of dopamine transporters and correlated behaviors in recombinant inbred mice.
    Janowsky A; Mah C; Johnson RA; Cunningham CL; Phillips TJ; Crabbe JC; Eshleman AJ; Belknap JK
    J Pharmacol Exp Ther; 2001 Aug; 298(2):634-43. PubMed ID: 11454925
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antidopaminergic effects of 1,2,3,4-tetrahydroisoquinoline and salsolinol.
    Antkiewicz-Michaluk L; Michaluk J; Romańska I; Papla I; Vetulani J
    J Neural Transm (Vienna); 2000; 107(8-9):1009-19. PubMed ID: 11041279
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo measures of dopaminergic radioligands in the rat brain: equilibrium infusion studies.
    Kilbourn MR; Sherman PS; Kuszpit K
    Synapse; 2002 Mar; 43(3):188-94. PubMed ID: 11793424
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolism and brain accumulation of tetrahydroisoquinoline (TIQ) a possible parkinsonism inducing substance, in an animal model of a poor debrisoquine metabolizer.
    Ohta S; Tachikawa O; Makino Y; Tasaki Y; Hirobe M
    Life Sci; 1990; 46(8):599-605. PubMed ID: 2308469
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-lasting inhibition of in vivo cocaine binding to dopamine transporters by 3 beta-(4-iodophenyl)tropane-2-carboxylic acid methyl ester: RTI-55 or beta CIT.
    Volkow ND; Gatley SJ; Fowler JS; Chen R; Logan J; Dewey SL; Ding YS; Pappas N; King P; MacGregor RR
    Synapse; 1995 Mar; 19(3):206-11. PubMed ID: 7784960
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and preliminary characterization of a high-affinity novel radioligand for the dopamine transporter.
    Dutta AK; Reith ME; Madras BK
    Synapse; 2001 Feb; 39(2):175-81. PubMed ID: 11180505
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Age-related decline in dopamine transporters: analysis of striatal subregions, nonlinear effects, and hemispheric asymmetries.
    van Dyck CH; Seibyl JP; Malison RT; Laruelle M; Zoghbi SS; Baldwin RM; Innis RB
    Am J Geriatr Psychiatry; 2002; 10(1):36-43. PubMed ID: 11790633
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship between blockade of dopamine transporters by oral methylphenidate and the increases in extracellular dopamine: therapeutic implications.
    Volkow ND; Wang GJ; Fowler JS; Logan J; Franceschi D; Maynard L; Ding YS; Gatley SJ; Gifford A; Zhu W; Swanson JM
    Synapse; 2002 Mar; 43(3):181-7. PubMed ID: 11793423
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.